Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. (Record no. 12264762)

MARC details
000 -LEADER
fixed length control field 00863 a2200217 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514052657.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200212s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0149-2195
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20021210
245 00 - TITLE STATEMENT
Title Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. MMWR. Morbidity and mortality weekly report
Date of publication, distribution, etc. Nov 2002
300 ## - PHYSICAL DESCRIPTION
Extent 1024-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Guideline; Journal Article; Practice Guideline
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anthrax
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anthrax Vaccines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotic Prophylaxis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bioterrorism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
773 0# - HOST ITEM ENTRY
Title MMWR. Morbidity and mortality weekly report
Related parts vol. 51
-- no. 45
-- p. 1024-6

No items available.